Cetera Investment Advisers
NUVB icon

Cetera Investment Advisers’s Nuvation Bio NUVB Stock Holding History

Cetera Investment Advisers’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$156K Sell
27,414
-2,300
-8% -$11.2K ﹤0.01% 4560
2026
Q1 		$127K Sell
29,714
-4,150
-12% -$23.1K ﹤0.01% 4397
2025
Q4 		$303K Buy
33,864
+13,460
+66% +$83.4K ﹤0.01% 3897
2025
Q3 		$75.5K Buy
20,404
+5,538
+37% +$15.1K ﹤0.01% 4376
2025
Q2 		$29K Buy
+14,866
New +$31K ﹤0.01% 4005

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Cetera Investment Advisers's NUVB Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Nuvation Bio (NUVB) stake by 7.7% in Q2 2026, selling an estimated $11.2K and leaving 27,414 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #4560.

Cetera Investment Advisers first reported a position in NUVB in Q2 2025 and has held it in 5 quarters since. The position peaked at $303K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Cetera Investment Advisers held 27,414 shares of Nuvation Bio worth $156K as of Q2 2026.
  • Cetera Investment Advisers sold 2,300 Nuvation Bio shares in Q2 2026, an estimated $11.2K.
  • Nuvation Bio made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4560 holding.
  • Cetera Investment Advisers first reported a position in Nuvation Bio in Q2 2025 and has held it in 5 quarters since.
  • Cetera Investment Advisers's Nuvation Bio position peaked at $303K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.